Stigmatization of People with Substance Dependency in Community Pharmacies
Research reveals that individuals with substance dependency often face stigma in community pharmacies, underscoring the need for compassionate, stigma-free healthcare services to support recovery.
Recent research highlights that individuals with substance dependency often experience stigma and discrimination when visiting community pharmacies. These negative attitudes from pharmacy staff include the use of derogatory language, segregation practices, and unwelcoming behaviors, which can impede their access to vital healthcare services. The study, conducted among pharmacy students and newly qualified pharmacists in Scotland, revealed inconsistent care: while some staff demonstrated compassion and professionalism, others fell short, potentially jeopardizing patients' recovery journeys.
Importantly, the research underscored that respectful treatment and empathy positively influence patient outcomes, encouraging a supportive environment conducive to recovery. Participants also emphasized the need to enhance pharmacy education, equipping future professionals to manage challenging interactions effectively.
The study monitored over 30,000 patients in Scotland receiving opioid agonist therapy—a treatment involving medications like methadone for opioid addiction—and noted that drug-related deaths in 2023 totaled 1,172. These findings align with ongoing efforts to destigmatize healthcare for individuals with substance dependency. Experts advocate for a shift toward holistic, non-judgmental care by pharmacists, who are increasingly seen as critical access points for health services within communities.
Adrian Mackenzie of Healthcare Improvement Scotland noted that reducing stigma can aid in harm reduction and foster a recovery-oriented system. The research also revealed societal issues, such as the misconception that individuals with substance dependency are beyond help or are morally responsible for their condition. Experts like Professor Andrew Radley stressed that community pharmacies are pivotal in supporting vulnerable populations and should serve as inclusive, caring environments.
This study, led by Dr. Natalie Weir from the University of Strathclyde, illustrates the importance of professionalism and empathy in pharmacy practice. It calls for enhanced training and awareness, ensuring that pharmacy teams provide equitable and dignified care to all patients, especially those battling addiction.
Source: https://medicalxpress.com/news/2025-09-people-substance-stigmatization-community-pharmacies.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Insights into Crohn's Disease: Targeting Transcription Factors RUNX2 and BHLHE40
Researchers have identified key transcription factors RUNX2 and BHLHE40 as pivotal in Crohn's disease inflammation. This discovery opens new avenues for targeted therapies to treat and prevent disease relapse.
Breakthrough Study Identifies 18 New Drug Targets for Multiple Sclerosis Treatment
A groundbreaking study from Karolinska Institutet has identified 18 new potential drug targets for multiple sclerosis, promising enhanced treatment options and drug repurposing opportunities.
Understanding Viral Mimicry in Cancer Cells and Its Impact on Immune Response
Research highlights how repetitive DNA in cancer cells mimics viral patterns, activating the immune system and impacting cancer progression, with significant implications for immunotherapy development.
Understanding Dormant Cancer Cells: How Chemotherapy Can Trigger Awakening and How Senolytic Drugs Might Prevent Relapse
New research reveals how chemotherapy can awaken dormant cancer cells, leading to relapse, and how senolytic drugs may offer a promising approach to prevent this by targeting the cellular environment that facilitates tumor reactivation.